David Chu, based in San Diego, CA, US, is currently a Executive Director, Clinical Development at Arcutis Biotherapeutics, Inc. (Nasdaq: ARQT), bringing experience from previous roles at The Janssen Pharmaceutical Companies of Johnson & Johnson and Scripps Clinic Medical Group. David Chu holds a 2001 - 2004 Residency in Dermatology @ NYU Medical Center. David Chu has 5 emails and 1 mobile phone number on RocketReach.